FDA scraps adcomm for Applied's rare disease drug ahead of November decision

[cafead]

via After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided that a planned advisory committee meeting won’t be required.

article source